ARTG 466926myLUX Patient App for an Android Mobile Device - Implantable cardiac device management application software
ARTG ID: 466926 · Boston Scientific Pty Ltd · Cardiac Pacemakers Inc a subsidiary of Boston Scientific Corporation · Class III · Started November 01, 2024
Good Name: Boston Scientific Pty Ltd - myLUX Patient App for an Android Mobile Device - Implantable cardiac device management application software
- Risk Class
- Class III
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 466926
- Start Date
- November 01, 2024
- Effective Date
- November 01, 2024
- Country
- United States of America
- Address
- 4100 Hamline Avenue North, St Paul, Minnesota, 55112-5798
Software app that is installed on non-medical off-the-shelf mobile devices and function by collecting and transmitting event, patient, and device data. The patient app is intended primarily for patient use.
Access comprehensive regulatory information for myLUX Patient App for an Android Mobile Device - Implantable cardiac device management application software in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 466926 and sponsored by Boston Scientific Pty Ltd, manufactured by Cardiac Pacemakers Inc a subsidiary of Boston Scientific Corporation in United States of America. The device registration started on November 01, 2024.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.